Introduction
The efficiency of gene transfer to hematopoietic stem cells must be improved in order to achieve therapeutic success.
1,2 Current gene transfer techniques employing murine retroviral vectors require cytokine exposure during ex vivo culture to stimulate progression through the cell cycle. 3, 4 However, ex vivo culture of hematopoietic stem cells may impair their viability and ability to engraft. 5, 6 Transforming growth factor-␤ (TGF-␤) are a group of pleiotropic cytokines with significant effects on hematopoiesis. 7 These cytokines are produced by marrow microenvironmental elements and have paracrine effects on hematopoietic cells, and have also been shown to be produced in an autocrine manner by primitive hematopoietic cells themselves. [8] [9] [10] [11] Our previous studies have shown that maintenance of murine long-term repopulating stem cells during ex vivo culture is affected by modulation of transforming growth factor-␤ activity. 12 The presence of TGF-␤1 during ex vivo culture had significant suppressive effects on both short and long-term repopulating activities and the addition of anti-TGF-␤ neutralizing antibody improved murine stem cell repopulating activity. Other investigators have also reported that abrogation of autocrine/paracrine TGF-␤ has beneficial effects on viability and proliferation of primitive hematopoietic cells. 8, [13] [14] [15] [16] Diminution of TGF-␤ activity during ex vivo culture by neutralizing antibodies or antisense oligonucleotides has been shown to increase retroviral gene transfer efficiency into committed progenitor cells such as CFU-GEMM (colony-forming unit granulocyte-erythroid-megakaryocyte-macrophage). 17 However, assessment of gene transfer into committed progenitor cells is often not predictive of the efficiency of gene transfer into true repopulating stem cells. 3, 18 In this study we use a murine congenic transplantation model to demonstrate that abrogation of TGF-␤ activity with a neutralizing antibody improves retroviral gene transfer efficiency into hematopoietic progenitor cells, as well as long-term repopulating cells. The combination of improved gene transfer efficiency and improved maintenance of stem cell numbers during transduction by abrogation of TGF-␤ activity may have a number of applications in the field of hematopoietic stem cell gene therapy.
Results
Culture in anti-TGF-␤1,2,3 neutralizing antibody increases transduction efficiency of murine CFU-C Murine post-5FU bone marrow mononuclear cells were prestimulated for 2 days and then transduced for 2 days with the G1Na.eco vector supernatant, in the presence of IL-3, IL-6, SCF and either the neutralizing anti-TGF-␤ antibody or a control IgG antibody (Figure 1 ). After this 4-day ex vivo culture and transduction period the cells were plated in methylcellulose and the number of 12-14-day CFU-C were enumerated. The total number of CFU-C present at the end of the culture and transduction period was slightly increased in the presence of anti-TGF-␤ compared with the control antibody (data not shown). Individual CFU-C were plucked, and polymerase chain reaction amplification of neo gene sequences in DNA from these colonies was carried out to quantify transduction efficiency. A total of seven separate transduction experiments was performed and the results are shown in Figure 2 . Gene transfer to these committed progenitor cells was very efficient even under control antibody conditions (mean 10.8/20 colonies neo positive), but increased significantly (mean 16.2/20 colonies neo positive) when prestimulation and transduction were done in the presence of the anti-TGF-␤ antibody (P Ͻ 0.007). Culture in the presence of anti-TGF-␤1,2,3 neutralizing antibody increases transduction efficiency of murine long-term repopulating cells Post-5FU C57BL/6J bone marrow mononuclear cells prestimulated and transduced as shown in Figure 1 were transplanted into congenitally anemic non-irradiated W/W v congenic mice. These recipient mice differ from the donor strain in ␤-hemoglobin phenotype, allowing engraftment of the erythroid compartment to be assessed by simple hemoglobin electrophoresis. 19, 20 Congenic donor stem cells also engraft completely without ablation due to low endogenous stem cell activity related to c-kit receptor mutations, and this strain has been used extensively in previous gene transfer studies. 19 A total of two separate transduction and transplantation experiments (Nos 6 and 7) in the presence of the control or anti-TGF-␤ antibodies at a concentration of 40 g/ml were performed. 19 PCR analysis and quantification of copy number of retroviral vector neo gene sequences in nucleated peripheral blood cells of recipient mice was performed monthly. Killing of the recipients to obtain bone marrow for similar analysis was performed at more than 4 months after transplantation. This time-point has been used to document effects of culture manipulations or transductions on long-term repopulating cells. Table 1 summarizes the data and Figure 3 shows two of the PCR analyses of peripheral blood and bone marrow DNA neo and actin sequences used for the copy number calculations given in the Table. The copy numbers of the marker gene in bone marrow cells harvested from recipient mice 4 months after transplantation in both experiments were significantly higher (P Ͻ 0.01) in the anti-TGF-␤ versus the control groups of recipient mice. The improvement was almost two-fold. In the peripheral blood, the neo copy number was also significantly higher in the anti-TGF-␤ group at each time-point.
To confirm the results of the PCR analysis, Southern blot analysis on bone marrow DNA from animals in experiment 7 was performed ( Figure 4 ). Band intensities after digestion with an enzyme (KpnI) that cuts in once in each LTR were compared with band intensities of a series of dilutions of single copy producer cell line DNA (G1Na) into normal murine bone marrow in order to calculate copy number (percentage of transduced cells) (Figure 4a ). This analysis confirmed the results from the semi-quantitative PCR. The animals receiving cells transduced in the presence of the anti-TGF-␤ antibody had a higher percentage of vector-containing marrow cells (P Ͻ 0.005). The overall levels were very high: if each cell had one insertion, a mean of 71.6% of cells in the anti-TGF-␤ group of mice contained the neo gene versus 25.8% in the control antibody group. In order to analyze insertion sites, a second blot using an enzyme that cuts once within the vector sequences (HindIII) was performed (Figure 4b ). Comparing the control to the anti-TGF-␤ groups, the patterns are much more complex, with a mean of 3.7 detectable bands per mouse compared with 7.8 per mouse (P Ͻ 0.01). The variable intensity of the insertion site analysis bands detected in individual mice suggests that this complex pattern was primarily due to a greater number of transduced repopulating cells, each contributing at different levels to reconstitution, instead of a greater number of insertions per repopulating cell.
Discussion
There are at least two major inter-related obstacles to successful retroviral gene therapy targeting hematopoietic stem cells: poor efficiency gene transfer to repopulating stem cells and loss of repopulating ability of stem cells resulting from the ex vivo culture conditions necessary to get retroviral vectors into target cells. 2, 5 In this report we have shown that gene transfer efficiency into both committed progenitors and long-term repopulating cells is increased by abrogation of autocrine/paracrine TGF-␤ activity during ex vivo culture and retroviral transduction. We have previously shown that TGF-␤ neutralizing antibody also increases repopulating ability of ex vivo cultured murine marrow cells several fold. 12 Thus the use of this approach during ex vivo culture and transduction may help overcome both obstacles to engraftment with genetically modified repopulating cells.
There are extensive earlier studies showing that ex vivo culture in the presence of TGF-␤ have significant suppressive effects on various assays of primitive hematopoietic cell function, including in vitro surrogates such as long-term culture initiating cells (LTCIC) and in vivo murine repopulating ability.
7,10-12,16,21-23 Pharmacologic doses given to mice profoundly suppress erythropoiesis and thrombopoiesis. 24 One mechanism for marrow suppression in human immunodeficiency virus infection may be stimulation of TGF-␤ production by marrow macrophages. 25 TGF-␤ are produced by marrow microenvironmental components such as stromal cells and macrophages, as well as by primitive hematopoietic progenitors themselves. [9] [10] [11] 21, 26, 27 Abrogation of autocrine or paracrine TGF-␤ with a neutralizing antibody or specific antisense oligonucleotides can improve the viability and proliferative potential of ex vivo cultured primitive hematopoietic cells. 9, 11, 21, [26] [27] [28] [29] We have previously shown that true murine repopulating stem cell activity as measured by the quantitative murine competitive repopulation assay is also increased two-to four-fold by inclusion of neutralizing TGF-␤ antibody during culture in IL-3, IL-6 and SCF. 12 A number of potential mechanisms have been suggested for these inhibitory actions. TGF-␤ have been shown to down-regulate the expression of receptors for positive regulatory cytokines such as GM-CSF, IL-3, G-CSF or SCF on various classes of hematopoietic cells. 23, 30, 31 In the presence of TGF-␤, primitive cells may not be able to respond to viability or proliferative signals of cytokines. As a result, these cells may become committed to a pathway ending in apoptosis.
15,32-34 TGF-␤ also appear to have direct antiproliferative properties due to prolongation or blockage of specific cell cycle checkpoints. 35, 36 Cells are arrested either in early or late G 1 , preventing progression past the G 1 -S phase restriction point. A number of events occurring in the TGF-␤ signal transduction pathway have been implicated, including down-regulation of c-myc, hypophosphorylation of the retinoblastoma gene product and up-regulation of the CdK inhibitor p15INK4B. 35, 37 These phenomena are better characterized in nonhematopoietic cell lines, but are beginning to be explored in primitive primary hematopoietic cells as well. 16, 21, 27 The inability of primitive cells exposed to TGF-␤ to progress through the cell cycle without undergoing apoptosis would be predicted to have significant deleterious effects on retroviral gene transfer efficiency, since cells must progress through mitosis in order to be successfully transduced. 4 During retroviral gene transfer, there are a number of potential sources of deleterious TGF-␤, including autocrine production by primitive target cells, paracrine production by other marrow hematopoietic elements such as stromal cells, or release of TGF-␤ by retroviral producer cell lines into supernatants used for transduction. 9, 11, 38 Increased retroviral gene transfer efficiency into committed progenitor cells after abrogation of TGF-␤ activity with antisense oligonucleotides or a neutralizing antibody has been previously reported. 17, 38 Our report is the first to document improved retroviral gene transfer into long-term repopulating cells. The neutralization of TGF-␤ during transduction may improve on the disappointing results from early human clinical trials of retroviral gene transfer, where only a very low percentage of repopulating stem cells appear to be transduced. 2, 18 Increased transduction efficiency along with improved preservation of repopulating ability during ex vivo culture in the presence of the anti-TGF-␤ neutralizing antibody may have greater impact when limited or no myeloablation can be given before reinfusion of transduced cell. 39, 40 This would be desirable in the genetic therapy of congenital non-malignant disorders such as Gaucher disease or chronic granulomatous disease.
41,42
Materials and methods
Mice
All mice were purchased from the Jackson Laboratories (Bar Harbor, ME, USA). Female C57BL/6J (homozygous for the single ␤-hemoglobin haplotype) mice were used as bone marrow donors. Female WBB6F 1 W/W v (heterozygous for single and diffuse ␤-hemoglobin haplotypes) mice were used as transplantation recipients. As shown in Figure 1 , donor mice were given 5-fluorouracil 150 mg/kg (Fluka, Ronkenhema, NY, USA) by tail vein injection and 48 h later bone marrow was harvested from tibiae and femora under sterile conditions. The cells were dispersed and cultured as described below. Cells were transplanted into recipient nonirradiated W/W v mice via tail vein injection.
Ex vivo cell culture and transduction Retroviral transduction of murine bone marrow cells was carried out as previously described. 3 Briefly, cell-free filtered retroviral supernatants were harvested from the G1Na.eco producer cell clone grown to near confluence in D10 media consisting of Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY, USA) supplemented with 10% fetal calf serum (Biofluids, Rockville, MD, USA). This producer cell clone was derived by transfection of the G1Na retroviral vector, containing the bacterial neomycin phosphotransferase coding sequences driven from the Moloney murine leukemia virus long terminal repeat (LTR) promoter, into the GP-E86 ecotropic packaging cell line and isolation of a high-titer (5 × 10 6 particles/ml) clone. 43, 44 Harvested C57BL/6J marrow cells were dispersed through a 21-gauge needle, layered on to LSM separation medium (Organon Teknika, Durham, NC, USA) and centrifuged at 469 g to isolate a mononuclear cell fraction, washed twice and resuspended in D10 at a concentration of 5-10 × 10 5 cells/ml with the addition of murine IL-3 (R&D Systems, Minneapolis, MN, USA), human IL-6 (Amgen, Thousand Oaks, CA, USA) and rat stem cell factor (Amgen) at concentrations of 10 ng/ml, 50 ng/ml and 100 ng/ml, respectively. After 48 h of prestimulation culture at 37°C, 5% CO 2 , the cells were collected and resuspended in fresh filtered retroviral supernatant plus fresh cytokines at the above concentrations and cultured. After 24 h, the cells were collected and resuspended in fresh retroviral supernatant and cytokines, and cultured for another 24 h. During both the prestimulation and transduction periods 20-40 g/ml of anti-TGF-␤1,2,3 murine monoclonal antibody in PBS without sodium azide (Genzyme, Framingham, MA, USA) or the same concentrations of a polyclonal mouse IgG control antibody were added to the marrow cell cultures. 45 Fresh antibody was added to each medium or retroviral supernatant change. After the completion of the 2-day prestimulation and 2-day transduction periods, the cells were collected from the culture plates, counted and injected via tail vein into nonirradiated W/W v recipient mice. The total number of cells injected was at least 5 × 10 5 mononuclear cells per W/W v recipient.
Hb electrophoresis
Heparinized peripheral blood (PB) was obtained from the retro-orbital sinus of W/W v mice at 2, 4 and 6 weeks after transplantation. Hemoglobin (Hb) phenotype was determined by cellulose acetate electrophoresis of heparinized PB as previously described, using reagents and a CliniScanII instrument from Helena Laboratories (Helena Laboratories, Beaumont, TX, USA). 20 The level of reconstitution by donor C57BL/6J marrow cells was determined from the relative intensities of the Hb diffuse versus Hb single (C57BL/6J) bands.
Colony-forming unit (CFU-C) analysis Cultured marrow cells were plated at 5 × 10 4 /ml in murine methylcellulose media (StemCell Technologies, Vancouver, Canada) containing 3 U/ml human erythropoietin (Amgen, Thousand Oaks, CA, USA) and 10% WEHI-3B-conditioned media. Colonies of greater than 50 cells were counted after incubation at 37°C in 5% CO 2 for 12-14 days. Individual 12-14-day CFU-C were plucked from methylcellulose, expelled into 50 l of ddH 2 O, heated at 99°C for 5 min and then digested for 1 h at 55°C after addition of 2 l proteinase K (20 mg/ml) to each tube. Tubes were heated again to 99°C for 10 min, then cooled to 4°C. Ten microliters of each digested CFU-C was used for PCR analysis of neo gene sequences as previously described. 43 AmpliTaq and reagents were purchased from Perkin-Elmer/Cetus (Norwalk, CT, USA). 32 P-dCTP (800 or 3000 Ci/mmol) (Amersham-Searle, Arlington Heights, IL, USA) was added at 0.25 l per 100 l reaction. The sequences of the primer pairs used to amplify a 430-bp segment of the neo gene are as follows: 5′ primer, 5′-TCC ATC ATG GCT GAT GCA ATG CGG C-3′; and 3′ primer, 5′-GAT AGA AGG CGA TGC GCT GCG AAT CG-3′. The ␤-actin gene was amplified using the primers 5′-CAT TGT GAT GGA CTC CGG AGA CGG-3′ and 5′-CAT CTC CTG CTC GAA GTC TAG AGC-3′. PCR conditions were as follows: initial denaturation at 94°C for 3 min; followed by 26 cycles consisting of denaturation at 94°C for 1 min, annealing at 55°C for 1 min, and elongation at 72°C for 2 min, followed by a final elongation at 72°C for 8 min. PCR products were separated on 8% polyacrylamide gels, dried gels were autoradiographed at room temperature for 2-4 days.
Analysis of gene transfer efficiency in recipient mice
Retro-orbital peripheral blood was obtained from each recipient mouse monthly for the first 4 months after transplantation and DNA was extracted using the QIAamp blood kit (Qiagen, Chatsworth, CA, USA). Marrow was harvested from the femora and tibiae after death of the mice 16 weeks after transplantation and processed using the non-organic DNA extraction kit (Oncor, Gaithersburg, MD, USA). For semi-quantitative PCR, 500 ng of DNA was used as a template with the neo and ␤-actin primers in conditions as above. In each PCR batch, reagent controls and a series of serial dilutions of singlecopy neo control cell line DNA mixed with normal murine marrow DNA were amplified concurrently. PCR products were separated on 8% polyacrylamide gels, dried and signal intensity quantified using the PhosphoImager scanner (Molecular Dynamics, Sunnyvale, CA, USA). Copy number was calculated from the normalized ratio of the neo signal to the actin signal for each sample as compared with the control single copy dilutions. All calculations were done using samples and controls amplified in the linear range.
Southern blot analysis
At least 4 months after transplantation, recipient W/W v mice were killed and high molecular weight DNA was extracted from the bone marrow. 10 g samples of marrow DNA were digested with KpnI or HindIII (Boehringer Mannheim, Indianapolis, IN, USA) and probed with a 430 bp neo gene probe generated by PCR. DNA from the G1Na.eco producer cell line was used as a positive control.
Statistical analysis
Statistical significance was assessed by using unpaired Student's t test for PCR results and paired tests for CFU-C number analysis using SigmaPlot software (SPSS ASG, Erkrath, Germany). Standard regression analysis was also carried out using Sigma Plot software.
